Showing results (381-390 of 489) with videos related to
Sort By:
Pageof 49
The British Journal of Dermatology|May 5, 2018
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)A D Irvine, A P Jones, P Beattie, et al.The British Journal of Dermatology|January 7, 2022
Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieuSanja Kezic, Maeve A McAleer, Ivone Jakasa, et al.RMD Open|February 8, 2023
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitisGerd R Burmester, Stanley B Cohen, Kevin L Winthrop, et al.Allergy|April 3, 2019
Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1βChristian Schwartz, Tara Moran, Sean P Saunders, et al.Allergy|October 19, 2020
Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysisDoreen Siegels, Annice Heratizadeh, Susanne Abraham, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 yearsChristopher G Bunick, Alan D Irvine, Jonathan I Silverberg, et al.Frontiers in Pediatrics|October 18, 2021
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference NetworkAnnegret Holm, Maroeska Te Loo, Leo Schultze Kool, et al.The British Journal of Dermatology|May 6, 2018
The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from patients with atopic dermatitisC P Harkins, M A McAleer, D Bennett, et al.Cell Metabolism|August 14, 2020
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome ActivationAlexander Hooftman, Stefano Angiari, Svenja Hester, et al.Journal of Dermatological Science|August 28, 2007
A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenitaHaihui Liao, Jane M Sayers, Neil J Wilson, et al.Pageof 49